Positron and GE extend buyout deadline

Article

Positron and GE Medical Systems have extended the deadline forPositron to complete its acquisition of GE's PET assets (SCAN7/31/96). The deadline, originally set for the end of last year,has been extended until March 31. Positron, of Houston, TX, saidthe

Positron and GE Medical Systems have extended the deadline forPositron to complete its acquisition of GE's PET assets (SCAN7/31/96). The deadline, originally set for the end of last year,has been extended until March 31. Positron, of Houston, TX, saidthe extension enables it to complete regulatory requirements andto finalize its financing package.

In other Positron news, the company last month announced two PETsystem orders: one to a mobile imaging company that will set upa mobile PET route in the Cleveland area, and another to a customerin the New York City area. Positron now has four PET scanner ordersin its backlog.

Also last month, Positron entered a sales and marketing agreementwith Beijing Aerospace Chang Feng Medical Devices, which willsell Positron PET systems in China. Chang Feng is the largestsupplier of CT and MRI scanners in China, according to Positron.

Recent Videos
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
Related Content
© 2025 MJH Life Sciences

All rights reserved.